RET and lung adenocarcinoma: The fusion gene of EML4-ALK was discovered in lung adenocarcinoma in 2007 [7]; since then, fusion alterations of ALK, RET, and ROS1 genes have been found in about 4–7% of patients with lung adenocarcinoma [8,9,10].